Research map: Subcutaneous Implantable Cardioverter-Defibrillator Therapy in Women

Back to the article

Papers in this map

  1. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death · Katja Zeppenfeld · 2022 · 3137 citations · Cited by this paper
  2. Marshall Bundle–Mediated Re-Entry After Combined Endo- and Epicardial PFA at the Mitral Isthmus Successfully Treated With VOMEI · 2026 · Related
  3. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure · Lars Køber · 2016 · 1763 citations · Cited by this paper
  4. Beyond the Surface · 2026 · Related
  5. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials · Stuart J. Connolly · 2000 · 1129 citations · Cited by this paper
  6. Intravascular Hemolysis and Pulsed-Field Ablation · 2026 · Related
  7. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark · Rikke Esberg Kirkfeldt · 2013 · 877 citations · Cited by this paper
  8. Effects of Pulsed Field Ablation for Pulmonary Vein Isolation on Vein of Marshall Electrograms · 2026 · Related
  9. An Entirely Subcutaneous Implantable Cardioverter–Defibrillator · Gust H. Bardy · 2010 · 781 citations · Cited by this paper
  10. Beyond the Earliest Signal · 2026 · Related
  11. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary · Sana M. Al‐Khatib · 2017 · 681 citations · Cited by this paper
  12. PVI Durability After PFA or RFA in Persistent-AF · 2026 · Related
  13. Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years · Thomas Kleemann · 2007 · 638 citations · Cited by this paper
  14. Is Low Shock Impedence Alone Good Enough To Omit DFT in SICD Implantation? · 2026 · Related
  15. Subcutaneous or Transvenous Defibrillator Therapy · Reinoud E. Knops · 2020 · 484 citations · Cited by this paper
  16. Hemolysis Related to PFA · 2026 · Related
  17. Inappropriate Implantable Cardioverter-Defibrillator Shocks · Johannes B. van Rees · 2011 · 452 citations · Cited by this paper
  18. Measure Twice, Ablate Once · 2026 · Related
  19. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry · Lucas V.A. Boersma · 2017 · 334 citations · Cited by this paper
  20. Hypertrophic Cardiomyopathy and Sudden Cardiac Death · 2026 · Related
  21. The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action · Éloi Marijon · 2023 · 305 citations · Cited by this paper
  22. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society · Cecilia M. Linde · 2018 · 299 citations · Cited by this paper
  23. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982–2018) · Thomas Olsen · 2019 · 237 citations · Cited by this paper
  24. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial · Michael Robert Gold · 2020 · 226 citations · Cited by this paper
  25. Women have lower chances than men to be resuscitated and survive out-of-hospital cardiac arrest · Marieke Tabo Blom · 2019 · 198 citations · Cited by this paper
  26. Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy · Pamela N. Peterson · 2009 · 197 citations · Cited by this paper
  27. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy · Tom F. Brouwer · 2016 · 179 citations · Cited by this paper
  28. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management · Louise R.A. Olde Nordkamp · 2015 · 142 citations · Cited by this paper
  29. Lifetime Risk for Sudden Cardiac Death in the Community · Brittany M Bogle · 2016 · 128 citations · Cited by this paper
  30. Breast Anatomy for the Interventionalist · Robert A. Jesinger · 2014 · 88 citations · Cited by this paper
  31. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR) · Andrea M. Russo · 2015 · 87 citations · Cited by this paper
  32. Important Differences in Mode of Death Between Men and Women With Heart Failure Who Would Qualify for a Primary Prevention Implantable Cardioverter-Defibrillator · Robert W. Rho · 2012 · 80 citations · Cited by this paper
  33. Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations · Jeff S. Healey · 2022 · 75 citations · Cited by this paper
  34. Long-Term Risk for Device-Related Complications and Reoperations After Implantable Cardioverter-Defibrillator Implantation · Isuru Ranasinghe · 2016 · 71 citations · Cited by this paper
  35. Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry · Rui Andre Providencia · 2016 · 65 citations · Cited by this paper
  36. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis · Roberto Rordorf · 2020 · 59 citations · Cited by this paper
  37. Characteristics and Outcomes of Sudden Cardiac Arrest During Sports in Women · Éloi Marijon · 2013 · 57 citations · Cited by this paper
  38. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System · Michael Robert Gold · 2023 · 51 citations · Cited by this paper
  39. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta‐Analysis of Randomized Trials and Propensity Score–Matched Studies · Khi Yung Fong · 2022 · 44 citations · Cited by this paper

Source: OpenAlex (CC0)